What You Should Know:
- Abbott launches new app, NeuroSphere myPath that will
allow patients to record their pain relief during the device trial period with
spinal cord stimulation or dorsal root ganglion therapy, simplify reporting
outcomes and connect patients to physicians who have real-time access to this
data
- NeuroSphere myPath will be available in the Apple App
Store in the coming weeks and will be compatible with the latest iOS operating
system
Abbott announced the
upcoming
Read More
Abbott
Why Some COVID-19 Testing Protocols Aren’t What You Think
While countries around the world continue to flounder with regards to COVID-19 testing, everyone is wondering how national governments could get things so horribly wrong. It’s true that governments have acted incompetently, leaders can make poor judgment calls, and optimistic testing targets are rarely achieved.
But the claims of various ambitious big pharma companies—about their ability to deliver on capacity and accuracy alike—have created a smokescreen for decision-makers, one that has
Read More
Digital Diabetes Market to Reach $1.5B by 2024, Research Finds
What You Should Know:
- The digital diabetes market is on track to reach $1.5
billion dollars by 2024, according to a new report by Research2Guidance.
- The confident growth of digital diabetes care will be driven by the growth of the global addressable market for digital diabetes services. Between 2019 and 2024, the number of diagnosed diabetics with access to smart devices is set to increase from 109 million to 180 million.
- Digital diabetes solutions have disrupted the
Read More
White House Coronavrius Task Force Doubles Down on Rapid Testing Strategy
What You Should Know:
- White house coronavirus task force doubles down on rapid testing strategy to fight the coronavirus as some states say they don’t have the supplies to comply with the federal government’s advice.
- This article was originally published by the Center for Public Integrity, a nonprofit investigative news organization based in Washington, D.C.
The White House coronavirus task force is doubling down on part of its strategy for halting the spread of the virus:
Read More
How Data-Driven Technology Holds The Promise of Better Outcomes for Vascular Patients
Abbott recently released global research on vascular patient care, designed to shine a light on the vascular patient journey. The report called “Beyond Intervention” uncovers the universal challenges faced by physicians who deliver vascular care, their patients, and the hospital administrators who support them. It also explores how the right use of technology and data could potentially enable more precise diagnoses and better treatment strategies to ensure the best possible patient
Read More
Abbott Receives CE Mark for World’s Smallest & Thinnest Glucose Sensor in Europe
What You Should Know:
- Abbott has received CE Mark (European approval)
for its next-generation FreeStyle Libre 3 system for people with diabetes.
- FreeStyle Libre 3 is the latest advancement from
Abbott’s FreeStyle Libre family of products and featuring the smallest, thinnest
continuous glucose monitoring (CGM) sensor (~size of two stacked U.S. pennies)
and a more environmentally sustainable system design.
Abbott, the worldwide
leader in continuous glucose
Read More
COVID-19 Infects Patient & Practitioner Demands, Unsettling the Future of Hospital Operations
Prior to the outbreak of COVID-19, the healthcare industry in the United States was in the midst of an intense refocusing on patient-centered care. This evolution was defined by a number of innovations, policies, and even federal reimbursement programs that prioritized emphasis on and impact on the patient experience. It led to changes in everything from the quality of hospital food, valet parking, and room amenities to fundamentally reimagined standards of care for even mundane procedures like
Read More
2020 Fortune/IBM Watson Health 100 Top Hospitals List
What You Should
Know:
- Fortune and
IBM Watson Health named the 100 Top Hospitals that are setting new standards
for using technology to improve operational efficiency, quality care and
safety.
- The rapid shift to virtual care amid COVID-19 put a bigger spotlight on the barriers impeding digital transformation, but this year’s top hospitals are leading the way for practical approaches to using telehealth and predictive modeling as well as data as a foundational measure to align
Read More
In-Depth: 32 FDA-Approved COVID-19 Testing Kits
What You Should Know:
- In-depth look list of FDA-approved COVID-19 test kits
The U.S. Food and Drug Administration (FDA) offers emergency use authorizations (EUAs) for unapproved products or new uses for approved items in urgent situations where no suitable alternatives exist. Dozens of companies have sought and received EUAs for their testing kits that screen for SARS-CoV-2 — more commonly referred to as COVID-19 or the novel coronavirus.
The FDA makes a
Read More
Omada Health Integrates With Abbot’s Freestyle Libre for People with Type 2 Diabetes
- Collaboration combines Abbott′s world-leading glucose sensing technology with Omada Health's best-in-class, proprietary digital coaching platform to provide personalized, on-the-go care.- As part of Omada’s expanded Type 2 diabetes offering, FreeStyle Libre will be the exclusive CGM delivered directly to participants’ doorsteps – expanding access to the technology for more people with diabetes.Abbott and Omada Health announced they are partnering to integrate Abbott's revolutionary FreeStyle
Read More
